Linagliptin 5mg Tablets$372.00
1–9 boxes
$372.00 each
10–24 boxes
8% off
25+ boxes
10% off
Linagliptin 5mg Tablets
SKU GME277Product Introduction
Linagliptin 5mg is a DPP-4 inhibitor used for adults with type 2 diabetes for linagliptin treatment. It helps improve glucose control by increasing incretin hormone activity, which raises glucose-dependent insulin release and lowers glucagon after meals. Linagliptin is not for type 1 diabetes or diabetic ketoacidosis.
How to use
Take Linagliptin 5mg once daily as prescribed, with or without food. Keep diet, activity, glucose monitoring, and HbA1c follow-up. Do not use it for diabetic ketoacidosis.
How it works
Linagliptin inhibits DPP-4, increasing active incretin hormones that support glucose-dependent insulin release and reduce glucagon after meals.
Common side effects
Possible effects include stuffy nose, sore throat, cough, diarrhea, headache, and mild stomach symptoms. Serious concerns include pancreatitis, allergic swelling, severe joint pain, blistering skin reaction, and heart-failure symptoms.
Important information
Review pancreatitis history, heart failure, kidney disease, liver disease, gallstones, alcohol use, pregnancy, breastfeeding, insulin, sulfonylureas, and other diabetes medicines.
Uses
Type 2 diabetes mellitus in adults when linagliptin therapy is prescribed.
Benefits
Improves glucose control with once-daily dosing and relatively low hypoglycemia risk when not combined with insulin or sulfonylureas.
What is Linagliptin 5mg used for?
Linagliptin 5mg is used to improve blood-glucose control in adults with type 2 diabetes.
Can Linagliptin 5mg cause low sugar?
Low sugar is less common alone, but risk rises with insulin or sulfonylurea medicines.
What pancreatitis symptoms matter?
Severe persistent abdominal pain, sometimes with vomiting or back pain, needs urgent review.
Is it used for type 1 diabetes?
No. Linagliptin is not for type 1 diabetes or diabetic ketoacidosis.
What monitoring is useful?
HbA1c, glucose patterns, hypoglycemia episodes with combination therapy, and side-effect symptoms guide treatment.
Linagliptin, DPP 4 inhibitor, Type 2 diabetes incretin medicine, HbA1c control, Pancreatitis warning, Low hypoglycemia risk, AR: Linagliptin أقراص, FR: Linagliptin comprimé, PT: Linagliptin comprimido, ES: Linagliptin tableta, RU: Linagliptin таблетки, ID: Linagliptin, VI: Linagliptin viên nén, MS: Linagliptin, TL: Linagliptin tableta, ZH-SG: Linagliptin 片剂